Stat News
STAT+: Hope for Kendall Square’s lab market
Drug pricing in Europe, AI deals for VC firms, and more biotech news from The Readout
S
Source
Stat News
Read full article at Stat News
Opens original article in a new tab
Advertisement
AI Bias Analysis
4 models · Takes ~15 seconds
Related Health Stories
Stat News
STAT+: Your sepsis algorithm shouldn’t require a time machine
In this edition of AI Prognosis: Quirky medical data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.
MedPage Today
Tranexamic Acid Makes Noncardiac Surgery Safer
(MedPage Today) -- A hospital policy of giving high transfusion-risk patients tranexamic acid for noncardiac surgery reduced blood transfusions without increasing thromboembolic risk, the TRACTION randomized trial showed. Hospitals giving tranexamic...
MedPage Today
Tailoring Treatment for Triple-Negative Breast Cancer in Older Patients
(MedPage Today) -- Despite being more commonly diagnosed in women ages 40 or younger, an estimated 10% to 15% of early triple-negative breast cancer (TNBC) cases are diagnosed in patients over 70. Current guidelines recommend the use of adjuvant...
MedPage Today
Optimizing Perioperative Therapy in Triple-Negative Breast Cancer
(MedPage Today) -- The treatment landscape for early-stage triple-negative breast cancer (TNBC) continues to evolve with evidence from ongoing neoadjuvant and adjuvant therapy trials. A major development was the KEYNOTE-522 trial that established...